Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Suicidality in Major Depressive Disorder
NCT00167154Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of risperidone in major depressive disorder (MDD), sponsored by University of Alabama at Birmingham. Started Jun 2004; status: completed.
02
Drugs
risperidone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00167154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167154.